Pulmonx (LUNG) Payables (2019 - 2025)

Pulmonx (LUNG) has reported Payables for 7 consecutive years, with $4.0 million the latest figure, recorded in Q4 2025.

• On a quarterly basis, Payables fell 42.72% year-over-year to $4.0 million in Q4 2025; TTM through Dec 2025 was $4.0 million, a 42.72% decrease from a year earlier, with the FY2025 full-year figure at $4.0 million, down 42.72% from the prior year.
• Payables was $4.0 million for Q4 2025 at Pulmonx, down from $6.5 million in the prior quarter.
• Over five years, Payables peaked at $18.9 million in Q4 2021 and troughed at $1.8 million in Q4 2022.
• A 5-year average of $7.8 million and a median of $6.0 million in 2022 frame the typical range for Payables.
• Across the five-year window, Payables sank 90.23% in 2022 and soared 180.31% in 2024, its largest moves.
• Over 5 years, Payables stood at $18.9 million in 2021, then slumped by 90.23% to $1.8 million in 2022, then jumped by 97.62% to $3.7 million in 2023, then surged by 91.76% to $7.0 million in 2024, then plunged by 42.72% to $4.0 million in 2025.
• The last three Payables figures came in at $4.0 million (Q4 2025), $6.5 million (Q3 2025), and $6.7 million (Q2 2025), per Business Quant data.